BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3661551)

  • 1. Once weekly intraperitoneal therapy for gram-positive peritonitis.
    Morse GD; Nairn DK; Walshe JJ
    Am J Kidney Dis; 1987 Oct; 10(4):300-5. PubMed ID: 3661551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
    Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S
    Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?
    Bailie GR; Morton R; Ganguli L; Keaney M; Waldek S
    Nephron; 1987; 46(3):316-8. PubMed ID: 3627326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.
    Whitby M; Edwards R; Aston E; Finch RG
    J Antimicrob Chemother; 1987 Mar; 19(3):351-7. PubMed ID: 3571051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal (IP) vancomycin therapy for CAPD peritonitis--a prospective, randomized comparison of intermittent v continuous therapy.
    Boyce NW; Wood C; Thomson NM; Kerr P; Atkins RC
    Am J Kidney Dis; 1988 Oct; 12(4):304-6. PubMed ID: 3177373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.
    Bastani B; Freer K; Read D; Bailey S; Sherman RA; Davis M; Engels D; Westervelt FB
    Nephron; 1987; 45(4):283-5. PubMed ID: 3587467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Bailie GR; Eisele G; Venezia RA; Yocum D; Hollister A
    Clin Pharmacokinet; 1992 Apr; 22(4):298-307. PubMed ID: 1606789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of once daily intra-peritoneal aztreonam and vancomycin in the treatment of CAPD peritonitis.
    Brown J; Altmann P; Cunningham J; Shaw E; Marsh F
    J Antimicrob Chemother; 1990 Jan; 25(1):141-7. PubMed ID: 2318749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen.
    Goldberg L; Clemenger M; Azadian B; Brown EA
    Am J Kidney Dis; 2001 Jan; 37(1):49-55. PubMed ID: 11136167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of peritonitis treated with intraperitoneal (i.p.) weekly vancomycin and i.p. daily netilmicin.
    Chadwick DH; Agarwal S; Vora BJ; Hair M; McKewan A; Gokal R
    J Nephrol; 1999; 12(5):318-21. PubMed ID: 10630696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W
    Nephron; 1986; 43(3):217-22. PubMed ID: 3724930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin kinetics during continuous ambulatory peritoneal dialysis.
    Bunke CM; Aronoff GR; Brier ME; Sloan RS; Luft FC
    Clin Pharmacol Ther; 1983 Nov; 34(5):631-7. PubMed ID: 6627823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of once-weekly vancomycin and once-daily gentamicin, intraperitoneally, for CAPD peritonitis.
    Bailie GR; Haqqie SS; Eisele G; Gorman T; Low CL
    Perit Dial Int; 1995; 15(6):269-71. PubMed ID: 7578507
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of intravenous vancomycin in the treatment of gram-positive peritonitis in long-term peritoneal dialysis.
    Krothapalli RK; Senekjian HO; Ayus JC
    Am J Med; 1983 Aug; 75(2):345-8. PubMed ID: 6881188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between intraperitoneal ciprofloxacin and intraperitoneal vancomycin and gentamicin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD).
    Friedland JS; Iveson TJ; Fraise AP; Winearls CG; Selkon JB; Oliver DO
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():77-81. PubMed ID: 2292548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis.
    Wong KM; Chan YH; Cheung CY; Chak WL; Choi KS; Leung SH; Leung J; Chau KF; Tsang DN; Li CS
    Am J Kidney Dis; 2001 Jul; 38(1):127-31. PubMed ID: 11431192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.
    Montañés Pauls B; Almiñana MA; Casabó Alós VG
    Eur J Pharm Sci; 2011 Jul; 43(4):212-6. PubMed ID: 21540106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin therapy for treatment of peritonitis in outpatients on peritoneal dialysis.
    Yorioka N; Taniguchi Y; Ito T; Katsutani M; Amimoto D; Masaki T; Nishida Y; Kushihata S; Oda H; Yamakido M
    Hiroshima J Med Sci; 1998 Sep; 47(3):105-7. PubMed ID: 9810781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD.
    Cheng IK; Fang GX; Chau PY; Chan TM; Tong KL; Wong AK; Li CS; Lo WK; Cheung KO; Kumana CR
    Perit Dial Int; 1998; 18(4):371-5. PubMed ID: 10505557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption of intraperitoneal antibiotics.
    Morse GD; Apicella MA; Walshe JJ
    Drug Intell Clin Pharm; 1988 Jan; 22(1):58-61. PubMed ID: 3349922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.